Read-Gene Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	4.75	5.08	3.34	14.36	14.12
Short-Term Investments	-	2.79	2.98	3.98	0	0
Cash & Short-Term Investments	-	7.54	8.07	7.32	14.36	14.12
Cash Growth	-	-6.54%	10.24%	-49.06%	1.72%	-
Accounts Receivable	-	3.69	2.63	2.44	1.76	1.37
Other Receivables	-	0	0	0.26	0.14	0.11
Total Trade Receivables	-	3.69	2.63	2.7	1.9	1.47
Inventory	0.07	0.08	0.12	0.13	0.03	0.03
Other Current Assets	0.08	0	0	0.02	0.04	0.06
Total Current Assets	9.02	9.56	8.76	8.5	9.15	8.62
Net Property, Plant & Equipment	5.72	5.69	5.93	6	5.98	6.27
Other Intangible Assets	-	0	0	0.13	0.32	0.5
Other Long-Term Assets	-	0	0	1	0.4	0
Total Assets	14.74	15.25	14.68	15.13	15.65	15.4
Accounts Payable	-	3.14	2.88	2.12	1.23	1.58
Accrued Expenses	-	0.29	0.24	-	-	-
Short-Term Debt	-	0	0	0	0.01	0.02
Other Current Liabilities	1.96	2.13	2.21	0	0	0
Total Current Liabilities	0.71	1.86	1.68	1.29	0.81	0.84
Long-Term Debt	-	6.93	6.59	7.52	7.06	4.86
Other Long-Term Liabilities	1.96	5.2	5.34	0	0	1.92
Total Long-Term Liabilities	8.19	8.3	7.91	7.52	7.06	6.78
Total Liabilities	10.86	12.14	11.67	10.97	10.14	9.98
Common Stock	0.59	0.59	0.59	0.59	0.59	0.59
Additional Paid-in Capital	5.42	5.42	5.64	5.64	5.42	5.42
Retained Earnings	-2.13	-2.9	-3.22	-2.07	-0.5	-0.59
Shareholders' Equity	3.88	3.11	3.02	4.16	5.51	5.42
Total Liabilities & Equity	14.74	15.25	14.68	15.13	15.65	15.4
Total Debt	-	6.93	6.59	7.52	7.07	4.88
Net Cash (Debt)	-	0.61	1.47	-0.2	7.29	9.24
Net Cash Growth	-	-58.30%	-	-	-21.07%	-
Net Cash Per Share	-	0.05	0.13	-0.02	0.62	0.78
Book Value	3.88	3.11	3.02	4.16	5.51	5.42
Book Value Per Share	0.33	0.26	0.26	0.35	0.47	0.46
Tangible Book Value	3.88	3.11	3.02	4.03	5.2	4.92
Tangible Book Value Per Share	0.33	0.26	0.26	0.34	0.44	0.42